SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-108513
Filing Date
2017-04-03
Accepted
2017-04-03 16:16:06
Documents
4
Period of Report
2017-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d354251d8k.htm 8-K 17787
2 EX-10.1 d354251dex101.htm EX-10.1 35858
3 EX-10.2 d354251dex102.htm EX-10.2 40286
4 GRAPHIC g354251ex102pg01a.jpg GRAPHIC 15068
  Complete submission text file 0001193125-17-108513.txt   116069
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 17734347
SIC: 2834 Pharmaceutical Preparations